[1] Bi, W., Fritsche, L.G., Mukherjee, B., Kim, S. and Lee, S., 2020. A fast and accurate method for
genome-wide time-to-event data analysis and its application to UK Biobank. The American Journal
of Human Genetics, 107(2), pp.222–233. doi:10.1016/j.ajhg.2020.06.003

[2] Cox, D.R., 1972. Regression models and life-tables. Journal of the Royal Statistical Society: Series B
(Methodological), 34(2), pp.187–220. doi:10.1111/j.2517-6161.1972.tb00899.x
[3] Dey, T., Lipsitz, S.R., Cooper, Z., Trinh, Q.D., Krzywinski, M. and Altman, N., 2022. Regression modeling of time-to-event data with censoring. Nature Methods, 19(8), pp.888–890. doi:10.1038/s41592-
022-01689-8
[4] Elston, R.C., Satagopan, J.M. and Sun, S., 2012. Genetic terminology. Methods in Molecular Biology,
850, pp.1–9. doi:10.1007/978-1-61779-555-8_1
[5] Flint, J. and Eskin, E., 2012. Genome-wide association studies in mice. Nature Reviews Genetics,
13(11), pp.807–817. doi:10.1038/nrg3335
[6] Ganesalingam, J. and Bowser, R., 2010. The application of biomarkers in clinical trials for motor
neuron disease. Biomarkers in Medicine, 4(2), pp.281–297. doi:10.2217/bmm.09.71
[7] Gentleman, R., Hornik, K. and Parmigiani, G., 2006. Use R! Springer, New York, NY.
[8] Hua, K., Wojdyla, D., Carnicelli, A., Granger, C., Wang, X. and Hong, H., 2025. Network metaanalysis with individual participant-level data of time-to-event outcomes using Cox regression. Statistics in Medicine, 44(5), p.e70027. doi:10.1002/sim.70027
[9] Joshi, P.K., Fischer, K., Schraut, K.E., Campbell, H., Esko, T. and Wilson, J.F., 2016. Variants near
CHRNA3/5 and APOE have age- and sex-related effects on human lifespan. Nature Communications,
7, p.11174. doi:10.1038/ncomms11174
[10] Joshi, P.K., Pirastu, N., Pietzner, M., Jansen, R., Robinson, M.R., Winkler, T.W., Sala, C.F. and
Wilson, J.F., 2017. Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle
factors with human longevity. Nature Communications, 8, p.910. doi:10.1038/s41467-017-00934-5
[11] Laber, S. and Cox, R.D., 2017. Mouse models of human GWAS hits for obesity and diabetes in the post-genomic era: time for reevaluation. Frontiers in Endocrinology, 8, p.11.
doi:10.3389/fendo.2017.00011
[12] Maeshima, K., Ide, S. and Babokhov, M., 2019. Dynamic chromatin organization without the 30-nm
fiber. Current Opinion in Cell Biology, 58, pp.95–104. doi:10.1016/j.ceb.2019.02.003
[13] Mondal, T., Rasmussen, S.H., Pandey, G.K., Isaksson, A. and Kanduri, C., 2010. Characterization of
the RNA content of chromatin. Genome Research, 20(7), pp.899–907. doi:10.1101/gr.103473.109
[14] Nagpal, C., Jeanselme, V. and Dubrawski, A., 2021. Deep parametric time-to-event regression with
time-varying covariates. Survival Prediction – Algorithms, Challenges and Applications, pp.184–193.
[15] Ojavee, S.E., Kousathanas, A., Trejo Banos, D., Orliac, E.J., Patxot, M., Läll, K., Mägi, R., Fischer,
K., Kutalik, Z. and Robinson, M.R., 2021. Genomic architecture and prediction of censored timeto-event phenotypes with a Bayesian genome-wide analysis. Nature Communications, 12(1), p.2337.
doi:10.1038/s41467-021-22538-w
[16] Rizvi, A.A., Karaesmen, E., Morgan, M., Preus, L., Wang, J., Sovic, M., Hahn, T. and SuchestonCampbell, L., 2018. gwasurvivr: an R package for genome-wide survival analysis. Bioinformatics,
35(11), pp.1968–1970. doi:10.1093/bioinformatics/bty920

[17] Sillanpää, E. and Shahzad, K., 2015. Supplier development and buyer-supplier relationship strategies – a literature review. International Journal of Procurement Management, 8(1-2), pp.227–250.
doi:10.1504/IJPM.2015.066283
[18] Staley, J.R., Blackshaw, J., Kamat, M.A., Ellis, S., Surendran, P., Sun, B.B., Paul, D.S., Freitag, D.,
Burgess, S., Danesh, J. et al., 2017. A comparison of Cox and logistic regression for use in genomewide association studies of cohort and case-cohort design. European Journal of Human Genetics,
25(7), pp.854–862. doi:10.1038/ejhg.2017.78
[19] Syed, H., Jørgensen, A.L. and Morris, A.P., 2016. Evaluation of methodology for the analysis
of ’time-to-event’ data in pharmacogenomic genome-wide association studies. Pharmacogenomics,
17(8), pp.907–915. doi:10.2217/pgs.16.19
[20] Syed, H., Jørgensen, A.L. and Morris, A.P., 2017. Survival GWAS-SV: software for the analysis of
genome-wide association studies of imputed genotypes with ”time-to-event” outcomes. BMC Bioinformatics, 18(1), p.265. doi:10.1186/s12859-017-1683-z
[21] Syed, H., Jørgensen, A.L. and Morris, A.P., 2016. SurvivalGWAS_Power: a user friendly tool for
power calculations in pharmacogenetic studies with ”time to event” outcomes. BMC Bioinformatics,
17(1), p.523. doi:10.1186/s12859-016-1407-9
[22] Uffelmann, E., Huang, Q.Q., Munung, N.S., de Vries, J., Okada, Y., Martin, A.R., Martin, H.C.,
Lappalainen, T. and Posthuma, D., 2021. Genome-wide association studies. Nature Reviews Methods
Primers, 1, p.59. doi:10.1038/s43586-021-00056-9
[23] Visscher, P.M., Wray, N.R., Zhang, Q., Sklar, P., McCarthy, M.I., Brown, M.A. and Yang, J., 2017.
10 Years of GWAS Discovery: Biology, Function, and Translation. The American Journal of Human
Genetics, 101(1), pp.5–22. doi:10.1016/j.ajhg.2017.06.005